Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.
Candidal balanitis when local therapy is not appropriate.
Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.
Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or tropical treatment are insufficient. Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.
Tinea unguinium (onychomycosis) when other agents are not considered appropriate.
Fluconazole is indicated in adults for the prophylaxis of:
Relapse of cryptococcal meningitis in patients with high risk of recurrence.
Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.
To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).
Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation.
Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:
Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.
Telegraphic Transfer (T/T), Letter of Credit (L/C), Cash Advance (CA)
200000 Per Day
If order is confirmed we will reimburse the sample cost
10 X 10 in a carton along with insert.
Main Export Market(s)
Africa, Middle East, South America, Central America, Australia, Asia